Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study.
暂无分享，去创建一个
R. Kurman | J. Thigpen | B. Bundy | N. Hornback | W. Creasman | C. Morrow | H. Homesley
[1] B. Bundy,et al. Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.
[2] J A Blessing,et al. Surgical Staging in Endometrial Cancer: Clinical—Pathologic Findings of a Prospective Study , 1984, Obstetrics and gynecology.
[3] V. Abeler,et al. Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: CLINICAL AND HISTOPATHOLOGIC STUDY OF 540 PATIENTS , 1980, Obstetrics and gynecology.
[4] J. Thigpen,et al. Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. , 1979, Cancer treatment reports.